BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31689517)

  • 1. Neoantigen-activated haploidentical T cell therapy for angioimmunoblastic T-cell lymphoma.
    Chen Y; Chen H; Gu W; Hu G
    Clin Immunol; 2020 Jan; 210():108296. PubMed ID: 31689517
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmission of angioimmunoblastic T-cell lymphoma by bone marrow transplant.
    Kreft A; Springer E; Geissinger E; Wagner EM; Bender K; Kolbe K; Hainz M; Rosenwald A; Herr W; Kirkpatrick CJ; Meyer RG
    Leuk Lymphoma; 2015 Apr; 56(4):1164-7. PubMed ID: 25120051
    [No Abstract]   [Full Text] [Related]  

  • 3. BCL2 expression in CD105 positive neoangiogenic cells and tumor progression in angioimmunoblastic T-cell lymphoma.
    Ratajczak P; Leboeuf C; Wang L; Brière J; Loisel-Ferreira I; Thiéblemont C; Zhao WL; Janin A
    Mod Pathol; 2012 Jun; 25(6):805-14. PubMed ID: 22322190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioimmunoblastic lymphadenopathy with trisomy 3: the cells of the malignant clone are T cells.
    Schlegelberger B; Nölle I; Feller AC; Bauer E; Grote W
    Hematol Pathol; 1990; 4(4):179-83. PubMed ID: 2074259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for monoclonal T lymphocyte proliferation in angioimmunoblastic lymphadenopathy.
    O'Connor NT; Crick JA; Wainscoat JS; Gatter KC; Stein H; Falini B; Mason DY
    J Clin Pathol; 1986 Nov; 39(11):1229-32. PubMed ID: 3491840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma].
    Tobinai K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():525-30. PubMed ID: 23134010
    [No Abstract]   [Full Text] [Related]  

  • 7. CD30 Expression by B and T Cells: A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified.
    Onaindia A; Martínez N; Montes-Moreno S; Almaraz C; Rodríguez-Pinilla SM; Cereceda L; Revert JB; Ortega C; Tardio A; González L; García S; Camacho FI; González-Vela C; Piris MA
    Am J Surg Pathol; 2016 Mar; 40(3):378-85. PubMed ID: 26574847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
    Sakata-Yanagimoto M
    Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
    Dunleavy K; Wilson WH
    Leuk Lymphoma; 2010 Sep; 51(9):1583-4. PubMed ID: 20795788
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angioimmunoblastic T-cell lymphoma].
    Izutsu K
    Nihon Rinsho; 2014 Mar; 72(3):519-23. PubMed ID: 24724413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment with mogamulizumab of refractory/relapsed angioimmunoblastic T-cell lymphoma following autologous stem cell transplantation.
    Oka S; Ono K; Nohgawa M
    Leuk Lymphoma; 2019 Jun; 60(6):1595-1597. PubMed ID: 30732495
    [No Abstract]   [Full Text] [Related]  

  • 12. Angioimmunoblastic T-cell lymphoma with dual genotype of TCR and IgH genes.
    Aung NY; Ohtake H; Iwaba A; Kato T; Ohe R; Tajima K; Nagase T; Yamakawa M
    Pathol Res Pract; 2011 May; 207(5):317-21. PubMed ID: 21377809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic findings in T-cell lymphoma of angioimmunoblastic lymphadenopathy.
    Younes A
    J Clin Oncol; 1996 Jul; 14(7):2188-9. PubMed ID: 8683255
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of cytogenetic findings for the clinical outcome in patients with T-cell lymphoma of angioimmunoblastic lymphadenopathy type.
    Schlegelberger B; Zwingers T; Hohenadel K; Henne-Bruns D; Schmitz N; Haferlach T; Tirier C; Bartels H; Sonnen R; Kuse R
    J Clin Oncol; 1996 Feb; 14(2):593-9. PubMed ID: 8636776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioimmunoblastic T-cell lymphoma developed with lymphocytic pleural effusion.
    Hosoki K; Okada S; Ichinohasama R; Yamaguchi M; Uchiyama B; Maeyama T
    Intern Med; 2007; 46(11):739-42. PubMed ID: 17541226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angioimmunoblastic T-cell lymphoma.
    Dogan A; Attygalle AD; Kyriakou C
    Br J Haematol; 2003 Jun; 121(5):681-91. PubMed ID: 12780782
    [No Abstract]   [Full Text] [Related]  

  • 17. Angioimmunoblastic T-cell lymphoma of cytotoxic T-cell phenotype containing a large B-cell proliferation with an undersized B-cell clonal product.
    Liao YL; Chang ST; Kuo SY; Lin SH; Chen CK; Chang KM; Chuang SS
    Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):185-9. PubMed ID: 19956067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput discovery of cancer-targeting TCRs.
    Bunse L; Green EW; Platten M
    Methods Enzymol; 2019; 629():401-417. PubMed ID: 31727251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation sequencing technologies accelerate advances in T-cell therapy for cancer.
    Yin Q; Tang J; Zhu X
    Brief Funct Genomics; 2019 Mar; 18(2):119-128. PubMed ID: 29982317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD200 (OX-2 membrane glycoprotein) is expressed by follicular T helper cells and in angioimmunoblastic T-cell lymphoma.
    Dorfman DM; Shahsafaei A
    Am J Surg Pathol; 2011 Jan; 35(1):76-83. PubMed ID: 21164290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.